Literature DB >> 26188131

Severe infective endocarditis in a healthy adult due to Streptococcus agalactiae.

Hiroaki Fujita1, Itaru Nakamura2, Ayaka Tsukimori1, Akihiro Sato3, Kiyofumi Ohkusu4, Tetsuya Matsumoto4.   

Abstract

A case of severe endocarditis, with complications of multiple infarction, meningitis, and ruptured mitral chordae tendineae, caused by Streptococcus agalactiae in a healthy man, is reported. Emergency cardiovascular surgery was performed on the day of admission. Infective endocarditis caused by S. agalactiae is very rare, particularly in a healthy adult. In addition, microbiological analysis revealed that S. agalactiae of sequence type (ST) 19, which belongs to serotype III, was present in the patient's vegetation, mitral valve, and blood culture. It was therefore concluded that the endocarditis was caused by ST19, which has been reported as a non-invasive type of S. agalactiae. This was an extremely rare case in which S. agalactiae of ST19 caused very severe endocarditis in an adult patient with no underlying disease.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Healthy; Infective endocarditis; Non-invasive strain; Severe; Streptococcus agalactiae

Mesh:

Year:  2015        PMID: 26188131     DOI: 10.1016/j.ijid.2015.07.009

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  3 in total

Review 1.  Perinatal Streptococcus agalactiae Epidemiology and Surveillance Targets.

Authors:  Lucy L Furfaro; Barbara J Chang; Matthew S Payne
Journal:  Clin Microbiol Rev       Date:  2018-08-15       Impact factor: 26.132

Review 2.  Group B Streptococcus (Streptococcus agalactiae).

Authors:  Vanessa N Raabe; Andi L Shane
Journal:  Microbiol Spectr       Date:  2019-03

Review 3.  Group B Streptococcal Colonization in African Countries: Prevalence, Capsular Serotypes, and Molecular Sequence Types.

Authors:  Sarah Shabayek; Patricia Ferrieri; Barbara Spellerberg
Journal:  Pathogens       Date:  2021-12-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.